US regulatory officials say they have identified not one but two supposed generic copies of the attention deficit hyperactive disorder (ADHD) treatment drug Concerta that have failed to demonstrate ...

Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

An internal US Food and Drug Administration (FDA) re-examination of previously submitted data has raised concerns that two generic medications used to treat attention ...

A generic attention deficit hyperactive disorder (ADHD) drug manufactured by Mallinckrodt has been found by the US Food and Drug Administration (FDA) to not be sufficiently equivalent to its reference ...

Medically reviewed by Lindsay Cook, PharmD Key Takeaways Concerta and Vyvanse are both long-acting stimulant medications taken to treat ADHD, but they differ in their formulations and additional uses.

Early drug treatment for ADHD in Sweden was tied to reduced risk of suicidal behavior, substance misuse, transport accidents, and crime. Benefits extended to recurrent events, possibly due to improved ...